BIOMAT Database Logo BIOMAT Database Logo

Phenobarbitone elimination rate after oral charcoal. 1980

P J Neuvonen, and E Elonen

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P J Neuvonen, and E Elonen
Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal.
November 1986, The Quarterly journal of medicine,
P J Neuvonen, and E Elonen
Effect of oral activated charcoal on quinine elimination.
January 1989, British journal of clinical pharmacology,
P J Neuvonen, and E Elonen
Digoxin toxicity: enhanced systemic elimination during oral activated charcoal therapy.
January 1984, Pharmacotherapy,
P J Neuvonen, and E Elonen
Oral activated charcoal to enhance theophylline elimination in an acute overdose.
June 1984, JAMA,
P J Neuvonen, and E Elonen
Failure of oral activated charcoal to accelerate the elimination of amiodarone and chloroquine.
November 1992, Human & experimental toxicology,
P J Neuvonen, and E Elonen
Evaluation of thermodynamic parameters for the activated charcoal-phenobarbitone adsorption system.
September 1999, Bollettino chimico farmaceutico,
P J Neuvonen, and E Elonen
Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination.
January 1986, Acta medica Scandinavica,
P J Neuvonen, and E Elonen
Activated charcoal increases digoxin elimination in patients.
January 1995, International journal of cardiology,
P J Neuvonen, and E Elonen
Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal.
November 1986, Annals of emergency medicine,
P J Neuvonen, and E Elonen
An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination.
April 1989, Journal of clinical pharmacology,
Copied contents to your clipboard!